BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15770077)

  • 1. Characterization of secretory intestinal transport of phenolsulfonphthalein.
    Itagaki S; Chiba M; Shimamoto S; Sugawara M; Kobayashi M; Miyazaki K; Hirano T; Iseki K
    Drug Metab Pharmacokinet; 2005 Feb; 20(1):72-8. PubMed ID: 15770077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of multidrug resistance-associated protein 2 to secretory intestinal transport of organic anions.
    Itagaki S; Chiba M; Kobayashi M; Hirano T; Iseki K
    Biol Pharm Bull; 2008 Jan; 31(1):146-8. PubMed ID: 18175959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The secretory intestinal transport of some beta-lactam antibiotics and anionic compounds: a mechanism contributing to poor oral absorption.
    Saitoh H; Gerard C; Aungst BJ
    J Pharmacol Exp Ther; 1996 Jul; 278(1):205-11. PubMed ID: 8764353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine.
    Saitoh H; Aungst BJ
    Pharm Res; 1995 Sep; 12(9):1304-10. PubMed ID: 8570526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
    Dahan A; Sabit H; Amidon GL
    Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory transport of p-aminohippuric acid across intestinal epithelial cells in Caco-2 cells and isolated intestinal tissue.
    Naruhashi K; Tamai I; Sai Y; Suzuki N; Tsuji A
    J Pharm Pharmacol; 2001 Jan; 53(1):73-81. PubMed ID: 11206195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose probenecid selectively inhibits urinary excretion of phenolsulfonphthalein in rats without affecting biliary excretion.
    Shin YJ; Lee JH; Oh JH; Lee YJ
    J Appl Toxicol; 2013 Jun; 33(6):511-5. PubMed ID: 22161506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of phenolsulfonphthalein transport system in Long-Evans Cinnamon rats.
    Itagaki S; Chiba M; Kobayashi M; Sugawara M; Kobayashi M; Hirano T; Iseki K
    Biochim Biophys Acta; 2008 Jan; 1778(1):270-5. PubMed ID: 17976528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted intestinal absorption of some beta-lactam antibiotics by an energy-dependent efflux system in rat intestine.
    Saitoh H; Fujisaki H; Aungst BJ; Miyazaki K
    Pharm Res; 1997 May; 14(5):645-9. PubMed ID: 9165537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental expression of renal organic anion transporters in rat kidney and its effect on renal secretion of phenolsulfonphthalein.
    Nomura M; Motohashi H; Sekine H; Katsura T; Inui K
    Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1640-9. PubMed ID: 22419695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
    Smeets PH; van Aubel RA; Wouterse AC; van den Heuvel JJ; Russel FG
    J Am Soc Nephrol; 2004 Nov; 15(11):2828-35. PubMed ID: 15504935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of urinary excretion of phenolsulfonphthalein in an animal model for Wilson's disease (Long-Evans Cinnamon rats) with that in normal Wistar rats: involvement of primary active organic anion transporter.
    Itagaki S; Shimamoto S; Hirano T; Iseki K; Sugawara M; Nishimura S; Fujimoto M; Kobayashi M; Miyazaki K
    J Pharm Pharm Sci; 2004 Jul; 7(2):227-34. PubMed ID: 15367380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of active secretion of phenolsulfonphthalein in the liver via Mrp2 (abcc2), an organic anion transporter.
    Itagaki S; Sugawara M; Kobayashi M; Miyazaki K; Iseki K
    Drug Metab Pharmacokinet; 2003; 18(4):238-44. PubMed ID: 15618741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2.
    Leier I; Hummel-Eisenbeiss J; Cui Y; Keppler D
    Kidney Int; 2000 Apr; 57(4):1636-42. PubMed ID: 10760098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fatty acid glycerol esters on intestinal absorptive and secretory transport of ceftibuten.
    Koga K; Murakami M; Kawashima S
    Biol Pharm Bull; 1999 Apr; 22(4):402-6. PubMed ID: 10328562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenolsulfonphthalein transport by potential-sensitive urate transport system.
    Itagaki S; Shimamoto S; Sugawara M; Kobayashi M; Miyazaki K; Hirano T; Iseki K
    Eur J Pharmacol; 2005 Aug; 518(2-3):83-9. PubMed ID: 16083873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically based pharmacokinetic model for the renal clearance of phenolsulfonphthalein and the interaction with probenecid and salicyluric acid in the dog.
    Russel FG; Wouterse AC; van Ginneken CA
    J Pharmacokinet Biopharm; 1987 Aug; 15(4):349-68. PubMed ID: 3681664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of multidrug resistance-associated protein 2 in acute hepatic failure rats.
    Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
    Eur J Pharmacol; 2006 Sep; 546(1-3):152-60. PubMed ID: 16899240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine.
    Okudaira N; Komiya I; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Nov; 295(2):717-23. PubMed ID: 11046110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.